Chinese Academy of Medical Sciences
339
21
22
81
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
2.1%
7 terminated/withdrawn out of 339 trials
92.0%
+5.5% vs industry average
19%
65 trials in Phase 3/4
6%
5 of 81 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (339)
International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer
Role: collaborator
Construction of a Benchmark for Breast Ultrasound AI Interpretation and Performance Evaluation of Multimodal AI Models
Role: collaborator
Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve Replacement
Role: collaborator
Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients
Role: collaborator
MxA-Guided Antiviral Treatment in Respiratory Viral Infections
Role: collaborator
Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients.
Role: collaborator
Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients
Role: collaborator
Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia
Role: collaborator
Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors
Role: collaborator
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
Role: collaborator
Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients
Role: collaborator
The Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin Lymphoma
Role: collaborator
Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
Role: collaborator
Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery Disease
Role: collaborator
An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder
Role: collaborator
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
Role: collaborator
A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma
Role: collaborator
Study of BEBT-209 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Patients With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Who Have Progressed After Prior Endocrine Therapy
Role: collaborator
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
Role: collaborator
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia (CML) Patients
Role: collaborator